Correlation Between Neuropace and Procept Biorobotics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neuropace and Procept Biorobotics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Procept Biorobotics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Procept Biorobotics Corp, you can compare the effects of market volatilities on Neuropace and Procept Biorobotics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Procept Biorobotics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Procept Biorobotics.

Diversification Opportunities for Neuropace and Procept Biorobotics

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Neuropace and Procept is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Procept Biorobotics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Procept Biorobotics Corp and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Procept Biorobotics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Procept Biorobotics Corp has no effect on the direction of Neuropace i.e., Neuropace and Procept Biorobotics go up and down completely randomly.

Pair Corralation between Neuropace and Procept Biorobotics

Given the investment horizon of 90 days Neuropace is expected to generate 2.58 times more return on investment than Procept Biorobotics. However, Neuropace is 2.58 times more volatile than Procept Biorobotics Corp. It trades about 0.36 of its potential returns per unit of risk. Procept Biorobotics Corp is currently generating about 0.07 per unit of risk. If you would invest  629.00  in Neuropace on September 2, 2024 and sell it today you would earn a total of  431.00  from holding Neuropace or generate 68.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Neuropace  vs.  Procept Biorobotics Corp

 Performance 
       Timeline  
Neuropace 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.
Procept Biorobotics Corp 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Procept Biorobotics Corp are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental indicators, Procept Biorobotics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Neuropace and Procept Biorobotics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neuropace and Procept Biorobotics

The main advantage of trading using opposite Neuropace and Procept Biorobotics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Procept Biorobotics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Procept Biorobotics will offset losses from the drop in Procept Biorobotics' long position.
The idea behind Neuropace and Procept Biorobotics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities